Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus

ClinicalTrials.gov ID: NCT04450394

Public ClinicalTrials.gov record NCT04450394. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 14, 2026, 8:35 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Parallel, Comparator-Controlled Trial to Evaluate the Safety and Efficacy of LY3209590 in Insulin-Naïve Patients With Type 2 Diabetes Mellitus

Study identification

NCT ID
NCT04450394
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
278 participants

Conditions and interventions

Interventions

  • Insulin Degludec Drug
  • LY3209590 Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2020
Primary completion
Oct 7, 2021
Completion
Oct 7, 2021
Last update posted
Nov 1, 2022

2020 – 2021

United States locations

U.S. sites
31
U.S. states
17
U.S. cities
29
Facility City State ZIP Site status
Syed Research Consultants Llc Sheffield Alabama 35660
National Research Institute - Huntington Park Huntington Park California 90255
National Research Institute - Wilshire Los Angeles California 90057
Catalina Research Institute, LLC Montclair California 91763
Encompass Clinical Research Spring Valley California 91978
CMR of Greater New Haven Waterbury Connecticut 06708
ALL Medical Research, LLC Cooper City Florida 33024
Jellinger and Lerman, MD PA dba The Center for Diabetes and Endocrine Care Fort Lauderdale Florida 33312
Suncoast Research Group Miami Florida 33135
New Horizon Research Center Miami Florida 33165 3338
Suncoast Clinical Research New Port Richey Florida 34652
Rophe Adult and Pediatric Medicine Union City Georgia 30291
Elite Clinical Trials Blackfoot Idaho 83221
Rocky Mountain Clinical Research Idaho Falls Idaho 83404
Elite Clinical Trials Rexburg Idaho 83440
Iowa Diabetes and Endocrinology Research Center West Des Moines Iowa 50265
Cotton O'Neil Diabetes and Endocrinology Center Topeka Kansas 66606
L-MARC Research Center Louisville Kentucky 40213
Endocrine and Metabolic Consultants Rockville Maryland 20852
Sky Clin Resch - Quinn HC Ridgeland Mississippi 39157
Lillestol Research LLC Fargo North Dakota 58104
Intend Research, LLC Norman Oklahoma 73069
Preferred Primary Care Physicians Uniontown Pennsylvania 15401
Holston Medical Group Bristol Tennessee 37620
Texas Diabetes & Endocrinology, P.A. Austin Texas 78731-4309
Dallas Diabetes Research Center Dallas Texas 75230
Juno Research Houston Texas 77040
Juno Research - Gessner Houston Texas 77074
Southern Endocrinology Associates Mesquite Texas 75149
Consano Clinical Research, LLC Shavano Park Texas 78231
Rainier Clinical Research Center Renton Washington 98057

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 33 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04450394, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 1, 2022 · Synced May 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04450394 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →